ADARx Pharmaceuticals, Inc. Common Stock

ADRXNASDAQ • USD
17.81 USD
↗ 0.18 (1.02%)AT CLOSE (03:59 PM EDT)
17.85
↗ 0.04 (0.22%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
17.85
↗ 0.04 (0.22%)
🔴Market: CLOSED

Shares of ADARx Pharmaceuticals, Inc. Common Stock (ADRX) are trading at $17.78. The technical outlook is "Neutral" based on moving average alignment, RSI, and MACD signals. Key drivers include a bullish Golden Cross on the moving averages.

Technical & fundamental data as of Oct 26, 2026.

Open?$17.77
High?$19.07
Low?$17.50
Prev. Close?$17.63
Volume?99.6K
Avg. Volume?N/A
VWAP?$17.99
Bid / Ask
Bid?$16.91 × 100
Ask?$22.50 × 100
Spread?$5.59
Midpoint?$19.71
Valuation & Ratios
Market Cap?1.9B
Shares Out?N/A
Float?52.5M
Float %?49.1%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Adarx Pharmaceuticals Inc is a late-clinical stage biotechnology company focused on developing next-generation siRNA therapeutics designed to treat a broad spectrum of diseases. Its pipeline includes three clinical-stage programs and two advanced preclinical programs. The three hepatic-targeted programs are agazisiran, onvuzosiran, and ADX-626, while the two extrahepatic-targeted programs are ADX-077 and ADX-199.
Employees
N/A
Market Cap
1.9B
Industry
N/A
Listed
2026-09-25
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestModerate
Short % of Float?3.63%Low
Short Interest?1.9M
Days to Cover?3.1
Free Float52.5M
Avg Daily Volume611.7K
Settlement Date2026-10-15